An interventional study of Wheelchair Skills Training Program in Wheelchair Mobility, Manual Wheelchair Skills Training and ARSACS, sponsored by Laval University. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-19.
Sponsored by Laval University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Myotonic Dystrophy with a site in Canada — 13 open to participants now, 16 under way, 4 of them phase 3. Myotonic Dystrophy · Canada.
Among the 28 studies in Myotonic Dystrophy with a site in Canada, this one is the 18th largest by planned enrollment of the 25 interventional ones that give a count, is one of 8 that started in 2024, is one of 8 with no phase, reaches primary completion later than 1 of the 15 other live ones, and was the 20th registered.
127 studies on the registry are indexed under Myotonic Dystrophy; 50 are open to participants now.
Browse Myotonic Dystrophy studies →13 of the 28 studies in Myotonic Dystrophy with a site in Canada are open now. Recruiting first, the newest first:
Avidity Biosciences, Inc. · Sites in Canada, Australia, Belgium and 7 more countries
Ages 7–16 · Men only
PepGen Inc · Sites in Canada
Sanofi · Sites in Canada, United States, Argentina and 3 more countries
Ages 10–55
PepGen Inc · Sites in Canada, New Zealand, Korea, Republic of and 1 more country
Ages 16–65
ARTHEx Biotech S.L. · Sites in Canada, United States, France and 4 more countries
Ages 18–64
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 35 Myotonic Dystrophy studies recruiting now, 15 (43%) set no upper age limit and 18 (51%) stop at 75 or younger; 22 take children under 18; 8 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 11 · Phase 3 7
First in 2008; this study’s year is marked. 8 started in 2024.
This study's planned enrollment of 20 is below the median of 40 across 68 interventional studies indexed under Myotonic Dystrophy.
Median enrollment 32 across the 25 interventional studies, 100 across the 3 observational. Of the 11 that completed or were terminated, 2 (18%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 28 have an industry lead sponsor. The 10 most frequent:
Laval University is the lead sponsor of 380 studies on the registry; 67 are open to participants now.
Laval University has 2 studies filed under Myotonic Dystrophy — fewer than ten, so there is no comparison to draw.
7 of the studies in Myotonic Dystrophy with a site in Canada that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05004129Phase 3AMO Pharma LimitedSafety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy | 2026-12-31 |
| NCT03981575Virginia Commonwealth UniversityEstab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) | 2026-12-01 |
| NCT06316778Université de SherbrookePelvic Floor Muscle Training for Women with Myotonic Dystrophy | 2026-12-30 |
| NCT06138743Sarepta Therapeutics, Inc.Study of SRP-1003 in Participants With Type 1 Myotonic Dystrophy | 2026-12-31 |
| NCT06185764Vertex Pharmaceuticals IncorporatedA Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1) | 2027-02-02 |
Add all 7 to your calendar (.ics) → With an account.
Among the 28 studies in Myotonic Dystrophy with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Wheelchairs (WC) are often provided to people with ARSACS and MD1 when they are not able to walk anymore. However, giving someone a MWC alone does not guarantee they will use it safely or properly. Many people who use WC need help from others to get around and they can not always do the things they like to do. This can lead to isolation, stress, and reduced quality of life. In addition, poor use of a MWC could lead to accidents and injuries. Our team recently showed that people with ARSACS have lower MWC skills than other adults who use MWC, and that teaching MWC skills to people with ARSACS seems to work. Now we are ready to test the program with more people with ARSACS and MD1 to see how it can improve MWC mobility and confidence. We also want to hear about people's expectations and experiences with MWC training. People who take part in research will answer questions before and after WC training, and we will follow up with them 3 months later to ask again about their WC use.
This projects directly adresses the mobility needs of people with ARSACS and MD1 who use MWC. Our results may improve how therapists provide training for MWC use, which may improve mobility, participation, and quality of life for people with ARSACS and MD1. Learning just one MWC skill could be life-changing. It could mean the difference between leaving the house or not, which could impact the ability to shop for groceries, see friends, or to have a job.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Standardized wheelchair skills training program.
Behavioral: Wheelchair Skills Training Program
Wait-list control group where participants will receive usual care from their clinician.
Participants will receive 5, 45-minute weekly WC skills training sessions that will take place in the community, in and around the participants home. Each session will be customized to the participant's' goals and based on the learner's impairments (i.e., weakness, spasticity, movement disorders \[e.g. ataxia, tremor\], contractures, cognition). The WSTP sessions will begin with a 5-minute review of goals/progress, followed by a 10-minute warm-up (wheeling activities, random practice of previously leaned skills); 20 minutes of attempting new skills (training on each skill will be carried to next session until the skills are learned or until the trainer and participant mutually agree that training should be abandoned; the trainer will periodically ask the participant to practice newly learned skills to incorporate variability of practice); 10 minute cool-down, during which the participant will practice skills in a self-controlled environment.
Wheelchair Skills Test Questionnaire (WST-Q)
Subjective report of participants' perceived manual wheelchair skills (performance and frequency). The WST-Q comprises 30 discrete manual WC skills. Skills are scored on a scale ranging from 0 (cannot execute skill) to 3 (can execute skill with expertise); a total percentage score (0-100%) is calculated with higher scores representing greater wheelchair skills. The WST-Q can be completed in \~15 minutes, has strong psychometric properties in English and French, and has been used extensively in clinical trials. The WST-Q has been validated by the study team for ARSACS.
Time frame: Baseline (T1); immediately post intervention up to 5 weeks after baseline (T2); 3-months follow-up (T3)
Wheelchair Skills Test (WST)
Objective rating of participants' perceived manual wheelchair skills (capacity). The WST comprises 30 discrete manual WC skills. Skills are scored on a scale ranging from 0 (cannot execute skill) to 3 (can execute skill with expertise); a total percentage score (0-100%) is calculated with higher scores representing greater wheelchair skills. The WST-Q can be completed in \~30 minutes, has strong psychometric properties in English and French, and has been used extensively in clinical trials. The WST-Q has been validated by the study team for ARSACS.
Time frame: Baseline (T1); immediately post intervention up to 5 weeks after baseline (T2); 3-months follow-up (T3)
Wheelchair Use Confidence Scale (WheelCon)
WC use confidence (i.e., belief in ability to accomplish specific tasks while using a manual WC) will be assessed using the Wheelchair Use Confidence Scale for Manual Wheelchair Users Short Form (WheelCon-M). The WheelCon-M comprises 21 statements related to confidence using a MWC in activities and environments, each rated on a scale from 0 ("not confident") to 10 ("completely confident"), producing a total mean score between 0 and10. Higher scores represent higher confidence. The WheelCon-M was validated for ARSACS.
Time frame: Baseline (T1); immediately post intervention up to 5 weeks after baseline (T2); 3-months follow-up (T3)
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2024; primary completion for Dec 2025, 15 months later.
Of 26 interventional studies with no phase under Myotonic Dystrophy, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 57. This study's planned 15 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.